Class information for:
Level 1: ANTIRETROVIRAL THERAPY//ROYAL FREE HIV MED//CD4 CELL COUNT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
2716 2166 33.1 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
61 2             HIV//AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV//ANTIRETROVIRAL THERAPY 29124
2716 1                   ANTIRETROVIRAL THERAPY//ROYAL FREE HIV MED//CD4 CELL COUNT 2166

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 ANTIRETROVIRAL THERAPY authKW 382879 16% 8% 357
2 ROYAL FREE HIV MED address 341035 3% 37% 66
3 CD4 CELL COUNT authKW 209729 3% 26% 58
4 HAART authKW 171969 7% 8% 155
5 AIDS journal 157578 14% 4% 310
6 VIRAL LOAD authKW 137429 6% 7% 139
7 HIGHLY ACTIVE ANTIRETROVIRAL THERAPY authKW 109216 4% 9% 88
8 INFECTIOUS DISEASES WoSSC 106132 65% 1% 1415
9 COPENHAGEN HIV PROGRAM address 105703 1% 50% 15
10 HIV MEDICINE journal 102176 4% 8% 89

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Infectious Diseases 106132 65% 1% 1415
2 Virology 22188 25% 0% 531
3 Immunology 17251 43% 0% 930
4 Medicine, General & Internal 2448 17% 0% 362
5 Microbiology 1683 13% 0% 278
6 Pharmacology & Pharmacy 863 14% 0% 302
7 Public, Environmental & Occupational Health 748 9% 0% 192
8 Social Sciences, Biomedical 131 1% 0% 26
9 Health Policy & Services 85 1% 0% 28
10 Medicine, Research & Experimental 23 2% 0% 54

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ROYAL FREE HIV MED 341035 3% 37% 66
2 COPENHAGEN HIV PROGRAM 105703 1% 50% 15
3 PRIMARY CARE POPULAT SCI 96867 4% 8% 88
4 CLIN INFECT DIS TROP MED 62672 1% 34% 13
5 AIDS THER Y EVALUAT 54996 1% 22% 18
6 INFECT POPULAT HLTH 51390 2% 7% 53
7 COPENHAGEN HIV PROGRAMME 50389 1% 15% 24
8 INFECT DIS 45449 23% 1% 498
9 X BICHAT MED 45105 0% 80% 4
10 EUROSIDA COORDINATING 43161 0% 44% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AIDS 157578 14% 4% 310
2 HIV MEDICINE 102176 4% 8% 89
3 ANTIVIRAL THERAPY 73691 5% 5% 99
4 HIV CLINICAL TRIALS 63220 2% 9% 48
5 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 61738 6% 3% 136
6 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 37243 3% 4% 68
7 AIDS RESEARCH AND HUMAN RETROVIRUSES 8787 3% 1% 58
8 AIDS PATIENT CARE AND STDS 7667 1% 2% 30
9 CLINICAL INFECTIOUS DISEASES 7462 4% 1% 83
10 JOURNAL OF INFECTIOUS DISEASES 7407 4% 1% 97

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ANTIRETROVIRAL THERAPY 382879 16% 8% 357 Search ANTIRETROVIRAL+THERAPY Search ANTIRETROVIRAL+THERAPY
2 CD4 CELL COUNT 209729 3% 26% 58 Search CD4+CELL+COUNT Search CD4+CELL+COUNT
3 HAART 171969 7% 8% 155 Search HAART Search HAART
4 VIRAL LOAD 137429 6% 7% 139 Search VIRAL+LOAD Search VIRAL+LOAD
5 HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 109216 4% 9% 88 Search HIGHLY+ACTIVE+ANTIRETROVIRAL+THERAPY Search HIGHLY+ACTIVE+ANTIRETROVIRAL+THERAPY
6 HIV RNA 97721 2% 21% 33 Search HIV+RNA Search HIV+RNA
7 HIV 82602 20% 1% 442 Search HIV Search HIV
8 CD4 LYMPHOCYTE COUNT 79739 1% 19% 30 Search CD4+LYMPHOCYTE+COUNT Search CD4+LYMPHOCYTE+COUNT
9 VIROLOGICAL FAILURE 65401 1% 22% 21 Search VIROLOGICAL+FAILURE Search VIROLOGICAL+FAILURE
10 VIREMIA COPY YEARS 56383 0% 100% 4 Search VIREMIA+COPY+YEARS Search VIREMIA+COPY+YEARS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 JENSEN-FANGEL, S , (2004) THE EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS.DANISH MEDICAL BULLETIN. VOL. 51. ISSUE 4. P. 371-392 116 42% 2
2 HOGG, R , LIMA, V , STERNE, JAC , GRABAR, S , BATTEGAY, M , BONAREK, M , MONFORTE, AD , ESTEVE, A , GILL, MJ , HARRIS, R , ET AL (2008) LIFE EXPECTANCY OF INDIVIDUALS ON COMBINATION ANTIRETROVIRAL THERAPY IN HIGH-INCOME COUNTRIES: A COLLABORATIVE ANALYSIS OF 14 COHORT STUDIES.LANCET. VOL. 372. ISSUE 9635. P. 293 -299 29 78% 511
3 PALELLA, FJ , DELANEY, KM , MOORMAN, AC , LOVELESS, MO , FUHRER, J , SATTEN, GA , ASCHMAN, DJ , HOLMBERG, SD , (1998) DECLINING MORBIDITY AND MORTALITY AMONG PATIENTS WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS INFECTION.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 338. ISSUE 13. P. 853 -860 14 70% 5889
4 CASOTTI, JAS , PASSOS, LN , OLIVEIRA, FJP , CERUTTI, C , (2011) FACTORS ASSOCIATED WITH PARADOXICAL IMMUNE RESPONSE TO ANTIRETROVIRAL THERAPY IN HIV INFECTED PATIENTS: A CASE CONTROL STUDY.BMC INFECTIOUS DISEASES. VOL. 11. ISSUE . P. - 36 75% 5
5 SRASUEBKUL, P , UNGSEDHAPAND, C , RUXRUNGTHAM, K , BOYD, MA , PHANUPHAK, P , COOPER, DA , LAW, MG , (2007) PREDICTIVE FACTORS FOR IMMUNOLOGICAL AND VIROLOGICAL ENDPOINTS IN THAI PATIENTS RECEIVING COMBINATION ANTIRETROVIRAL TREATMENT.HIV MEDICINE. VOL. 8. ISSUE 1. P. 46-54 35 83% 8
6 ABROGOUA, DP , KABLAN, BJ , KAMENAN, BAT , AULAGNER, G , N'GUESSAN, K , ZOHORE, C , (2012) ASSESSMENT OF THE IMPACT OF ADHERENCE AND OTHER PREDICTORS DURING HAART ON VARIOUS CD4 CELL RESPONSES IN RESOURCE-LIMITED SETTINGS.PATIENT PREFERENCE AND ADHERENCE. VOL. 6. ISSUE . P. 227-237 39 64% 6
7 SABIN, CA , (2009) EARLY ANTIRETROVIRAL THERAPY: THE ROLE OF COHORTS.CURRENT OPINION IN HIV AND AIDS. VOL. 4. ISSUE 3. P. 200-205 43 63% 3
8 PHILLIPS, AN , STASZEWSKI, S , WEBER, R , KIRK, O , FRANCIOLI, P , MILLER, V , VERNAZZA, P , LUNDGREN, JD , LEDERGERBER, B , (2001) HIV VIRAL LOAD RESPONSE TO ANTIRETROVIRAL THERAPY ACCORDING TO THE BASELINE CD4 CELL COUNT AND VIRAL LOAD.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 286. ISSUE 20. P. 2560 -2567 31 89% 166
9 RAJASURIAR, R , GOUILLOU, M , SPELMAN, T , READ, T , HOY, J , LAW, M , CAMERON, PU , PETOUMENOS, K , LEWIN, SR , (2011) CLINICAL PREDICTORS OF IMMUNE RECONSTITUTION FOLLOWING COMBINATION ANTIRETROVIRAL THERAPY IN PATIENTS FROM THE AUSTRALIAN HIV OBSERVATIONAL DATABASE.PLOS ONE. VOL. 6. ISSUE 6. P. - 42 58% 11
10 HSU, DC , QUIN, JW , (2010) CLINICAL AUDIT: VIROLOGICAL AND IMMUNOLOGICAL RESPONSE TO COMBINATION ANTIRETROVIRAL THERAPY IN HIV PATIENTS AT A SYDNEY SEXUAL HEALTH CLINIC.INTERNAL MEDICINE JOURNAL. VOL. 40. ISSUE 4. P. 265 -274 27 96% 0

Classes with closest relation at Level 1


Rank Class id link
1 2491 ADHERENCE//ANTIRETROVIRAL THERAPY//AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
2 6181 ATAZANAVIR//RITONAVIR//LOPINAVIR
3 12516 EFAVIRENZ//NEVIRAPINE//CYP2B6
4 545 HIV DRUG RESISTANCE//HIV 1 DRUG RESISTANCE//TRANSMITTED DRUG RESISTANCE
5 9909 RETENTION IN CARE//ENGAGEMENT IN CARE//LINKAGE TO CARE
6 3091 LOSS TO FOLLOW UP//ANTIRETROVIRAL THERAPY//HLTH ECON EPIDEMIOL OFF
7 12349 AIDS & PUBLIC POLICY JOURNAL//COSTS PER PATIENT YEAR//LONDON SPECIALISED COMMISSIONING GRP
8 28171 IMMUNE BASED THERAPY//AIDS MED ONCOL//CLIN MOL RETROVIROL SECT
9 7021 RALTEGRAVIR//DOLUTEGRAVIR//ETRAVIRINE
10 6937 HIV INCUBATION DISTRIBUTION//REPORTING DELAY//BACK CALCULATION

Go to start page